Skip to content

Zhengye Biotechnology Holding Limited

ZYBT

CIK 0001975641

← back to feed
Revenue (TTM)
¥25.53M
−87.9% YoY FY Dec 2025
Net Income (TTM)
−¥9.98M
−744.0% YoY FY Dec 2025
EPS Diluted (TTM)
¥0.03
−95.7% YoY FY Dec 2025
Gross Margin
13.4%
FY Dec 2025
Operating Margin
-39.5%
FY Dec 2025
Net Margin
-39.1%
FY Dec 2025
Free Cash Flow (TTM)
¥1.77M
FY Dec 2025
Cash
¥2.55M
FY Dec 2025
Total Debt
¥9.97M
FY Dec 2025
Shares Outstanding
47.39M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings